We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current TSBX market cap is 11.36M. The company's latest EPS is USD -2.3867 and P/E is -0.21.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Revenue | 19.31M | 0 | 0 | 0 | 0 |
| Operating Income | -394k | -21.85M | -18.93M | -17.86M | -18.37M |
| Net Income | 68k | -21.54M | -17.32M | -16.41M | -17.03M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 101.29M | 73.3M | 19.31M |
| Operating Income | 32.99M | -31.63M | -59.03M |
| Net Income | 33.27M | -30.83M | -55.2M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Assets | 92.26M | 74.77M | 131.31M | 112.82M | 58.48M |
| Total Liabilities | 20.52M | 23.39M | 17.41M | 14.15M | 14.84M |
| Total Equity | -100.22M | -120.61M | 113.9M | 98.67M | 43.64M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 187.24M | 114.94M | 112.82M |
| Total Liabilities | 97.34M | 44.46M | 14.15M |
| Total Equity | -81.85M | -101.47M | 98.67M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Operating | -17.17M | -31.86M | -50.65M | -66.15M | -50.96M |
| Investing | 16.5M | 19.48M | -22.79M | -28.09M | 57.29M |
| Financing | -815k | -1.08M | 77.22M | 77.05M | 11k |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -45.63M | -71.06M | -66.15M |
| Investing | -3.35M | -14.93M | -28.09M |
| Financing | 79.95M | -2.66M | 77.05M |
| Market Cap | 11.36M |
| Price to Earnings Ratio | -0.21 |
| Price to Sales Ratio | 0.59 |
| Price to Cash Ratio | 0.64 |
| Price to Book Ratio | 0.11 |
| Dividend Yield | - |
| Shares Outstanding | 23.13M |
| Average Volume (1 week) | 55.01k |
| Average Volume (1 Month) | 89.56k |
| 52 Week Change | -79.19% |
| 52 Week High | 5.75 |
| 52 Week Low | 0.403 |
| Spread (Intraday) | 0.08 (16.05%) |
| Company Name | Turnstone Biologics Corporation |
| Address |
9310 athena circle, suite 300 la jolla, california 92037 |
| Website | https:// |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
